Correlation Between Veracyte and Halozyme Therapeutics
Can any of the company-specific risk be diversified away by investing in both Veracyte and Halozyme Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Halozyme Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Halozyme Therapeutics, you can compare the effects of market volatilities on Veracyte and Halozyme Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Halozyme Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Halozyme Therapeutics.
Diversification Opportunities for Veracyte and Halozyme Therapeutics
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Veracyte and Halozyme is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Halozyme Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Halozyme Therapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Halozyme Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Halozyme Therapeutics has no effect on the direction of Veracyte i.e., Veracyte and Halozyme Therapeutics go up and down completely randomly.
Pair Corralation between Veracyte and Halozyme Therapeutics
Given the investment horizon of 90 days Veracyte is expected to generate 0.56 times more return on investment than Halozyme Therapeutics. However, Veracyte is 1.79 times less risky than Halozyme Therapeutics. It trades about 0.3 of its potential returns per unit of risk. Halozyme Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 3,412 in Veracyte on August 28, 2024 and sell it today you would earn a total of 698.00 from holding Veracyte or generate 20.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Halozyme Therapeutics
Performance |
| Timeline |
| Veracyte |
| Halozyme Therapeutics |
Veracyte and Halozyme Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Halozyme Therapeutics
The main advantage of trading using opposite Veracyte and Halozyme Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Halozyme Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Halozyme Therapeutics will offset losses from the drop in Halozyme Therapeutics' long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Halozyme Therapeutics vs. Agios Pharm | Halozyme Therapeutics vs. Insmed Inc | Halozyme Therapeutics vs. Ultragenyx | Halozyme Therapeutics vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |